FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2911492027> ?p ?o ?g. }

• W2911492027 endingPage "113" @default.
• W2911492027 startingPage "101" @default.
• W2911492027 abstract "Abstract Aims Proton pump inhibitors (PPIs) are widely used in patients receiving percutaneous coronary intervention to prevent gastric bleeding, but whether PPIs are beneficial for the heart is controversial. Here, we investigated the effects of lansoprazole on cardiac hypertrophy and heart failure, as well as the underlying mechanisms. Methods and results Adult male C57 mice were subjected to transverse aortic constriction (TAC) or sham surgery and then were treated with lansoprazole or vehicle for 5 weeks. In addition, cultured neonatal rat ventricular cardiomyocytes and fibroblasts were exposed to angiotensin II in the presence or absence of lansoprazole. At 5 weeks after TAC, the heart weight/body weight ratio was lower in lansoprazole-treated mice than in untreated mice, as was the lung weight/body weight ratio, while left ventricular (LV) fractional shortening and the maximum and minimum rates of change of the LV pressure were higher in lansoprazole-treated mice, along with less cardiac fibrosis. In cultured cardiomyocytes, lansoprazole inhibited angiotensin II-induced protein synthesis and hypertrophy, as well as inhibiting proliferation of fibroblasts. Lansoprazole decreased myocardial levels of phosphorylated Akt, phosphorylated glycogen synthase kinase 3β, and active β-catenin in TAC mice and in angiotensin II-stimulated cardiomyocytes. After overexpression of active β-catenin or knockdown of H+/K+-ATPase α-subunit, lansoprazole still significantly attenuated myocyte hypertrophy. Conclusion Lansoprazole inhibits cardiac remodelling by suppressing activation of the Akt/GSK3β/β-catenin pathway independent of H+/K+-ATPase inhibition, and these findings may provide a novel insight into the pharmacological effects of PPIs with regard to alleviation of cardiac remodelling." @default.
• W2911492027 created "2019-02-21" @default.
• W2911492027 creator A5010525798 @default.
• W2911492027 creator A5022863735 @default.
• W2911492027 creator A5029741432 @default.
• W2911492027 creator A5029898646 @default.
• W2911492027 creator A5033867293 @default.
• W2911492027 creator A5043993720 @default.
• W2911492027 creator A5050179322 @default.
• W2911492027 creator A5053653597 @default.
• W2911492027 creator A5072833248 @default.
• W2911492027 creator A5079450919 @default.
• W2911492027 creator A5079920320 @default.
• W2911492027 creator A5080106073 @default.
• W2911492027 creator A5080293775 @default.
• W2911492027 date "2019-01-24" @default.
• W2911492027 modified "2023-10-14" @default.
• W2911492027 title "Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin" @default.
• W2911492027 cites W1578396116 @default.
• W2911492027 cites W1968363634 @default.
• W2911492027 cites W1971907225 @default.
• W2911492027 cites W1978029099 @default.
• W2911492027 cites W1981228412 @default.
• W2911492027 cites W1984514934 @default.
• W2911492027 cites W1987061291 @default.
• W2911492027 cites W1987788803 @default.
• W2911492027 cites W1991692740 @default.
• W2911492027 cites W1992870062 @default.
• W2911492027 cites W2001374906 @default.
• W2911492027 cites W2004168283 @default.
• W2911492027 cites W2008421466 @default.
• W2911492027 cites W2013607638 @default.
• W2911492027 cites W2015016880 @default.
• W2911492027 cites W2035369713 @default.
• W2911492027 cites W2048869581 @default.
• W2911492027 cites W2051239863 @default.
• W2911492027 cites W2052867135 @default.
• W2911492027 cites W2054848045 @default.
• W2911492027 cites W2070515279 @default.
• W2911492027 cites W2070788396 @default.
• W2911492027 cites W2087160727 @default.
• W2911492027 cites W2096161049 @default.
• W2911492027 cites W2096215047 @default.
• W2911492027 cites W2101821830 @default.
• W2911492027 cites W2105537982 @default.
• W2911492027 cites W2120285489 @default.
• W2911492027 cites W2121166230 @default.
• W2911492027 cites W2127181560 @default.
• W2911492027 cites W2142083184 @default.
• W2911492027 cites W2143730872 @default.
• W2911492027 cites W2152376036 @default.
• W2911492027 cites W2167711201 @default.
• W2911492027 cites W2172775913 @default.
• W2911492027 cites W2299887796 @default.
• W2911492027 cites W2302382872 @default.
• W2911492027 cites W2508503189 @default.
• W2911492027 cites W2582216571 @default.
• W2911492027 cites W2588790905 @default.
• W2911492027 cites W2596352389 @default.
• W2911492027 cites W2616715279 @default.
• W2911492027 cites W2762354894 @default.
• W2911492027 cites W2767536906 @default.
• W2911492027 cites W2768509703 @default.
• W2911492027 cites W2805552314 @default.
• W2911492027 cites W2807330573 @default.
• W2911492027 cites W4236531408 @default.
• W2911492027 doi "https://doi.org/10.1093/cvr/cvz016" @default.
• W2911492027 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30689763" @default.
• W2911492027 hasPublicationYear "2019" @default.
• W2911492027 type Work @default.
• W2911492027 sameAs 2911492027 @default.
• W2911492027 citedByCount "28" @default.
• W2911492027 countsByYear W29114920272019 @default.
• W2911492027 countsByYear W29114920272020 @default.
• W2911492027 countsByYear W29114920272021 @default.
• W2911492027 countsByYear W29114920272022 @default.
• W2911492027 countsByYear W29114920272023 @default.
• W2911492027 crossrefType "journal-article" @default.
• W2911492027 hasAuthorship W2911492027A5010525798 @default.
• W2911492027 hasAuthorship W2911492027A5022863735 @default.
• W2911492027 hasAuthorship W2911492027A5029741432 @default.
• W2911492027 hasAuthorship W2911492027A5029898646 @default.
• W2911492027 hasAuthorship W2911492027A5033867293 @default.
• W2911492027 hasAuthorship W2911492027A5043993720 @default.
• W2911492027 hasAuthorship W2911492027A5050179322 @default.
• W2911492027 hasAuthorship W2911492027A5053653597 @default.
• W2911492027 hasAuthorship W2911492027A5072833248 @default.
• W2911492027 hasAuthorship W2911492027A5079450919 @default.
• W2911492027 hasAuthorship W2911492027A5079920320 @default.
• W2911492027 hasAuthorship W2911492027A5080106073 @default.
• W2911492027 hasAuthorship W2911492027A5080293775 @default.
• W2911492027 hasConcept C11960822 @default.
• W2911492027 hasConcept C126322002 @default.
• W2911492027 hasConcept C134018914 @default.
• W2911492027 hasConcept C167414201 @default.
• W2911492027 hasConcept C185592680 @default.
• W2911492027 hasConcept C2776409635 @default.
• W2911492027 hasConcept C2778198053 @default.

• next